List of Contents

Blood Transfusion Devices Market Size, Share, and Trends 2024 to 2034

Blood Transfusion Devices Market (By Product: Autotransfusion, Systems and Consumables & Accessories; By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, Others; By End Use: Hospitals, Specialty Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : August 2023
  • Report Code : 2276
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Transfusion Devices Market 

5.1. COVID-19 Landscape: Blood Transfusion Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Transfusion Devices Market, By Product

8.1. Blood Transfusion Devices Market, by Product, 2023-2032

8.1.1 Autotransfusion

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Systems and Consumables & Accessories

8.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Blood Transfusion Devices Market, By Application

9.1. Blood Transfusion Devices Market, by Application, 2023-2032

9.1.1. Cardiovascular Surgeries

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Orthopedic Surgeries

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Neurological Surgeries

9.1.3.1. Market Revenue and Forecast (2021-2032)

9.1.4. Obstetrics & Gynecological Surgeries

9.1.4.1. Market Revenue and Forecast (2021-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Blood Transfusion Devices Market, By End Use 

10.1. Blood Transfusion Devices Market, by End Use, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Specialty Clinics

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Blood Transfusion Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.2. Market Revenue and Forecast, by Application (2021-2032)

11.1.3. Market Revenue and Forecast, by End Use (2021-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2032)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2032)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.2. Market Revenue and Forecast, by Application (2021-2032)

11.2.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2032)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2032)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2032)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2032)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.2. Market Revenue and Forecast, by Application (2021-2032)

11.3.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2032)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2032)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2032)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2032)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.2. Market Revenue and Forecast, by Application (2021-2032)

11.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2032)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2032)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2032)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2032)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.2. Market Revenue and Forecast, by Application (2021-2032)

11.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2032)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2032)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2032)

Chapter 12. Company Profiles

12.1. Immucor, Inc. (U.S.)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. BD (U.S.)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. B. Braun Melsungen AG (Germany)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Terumo Corporation (Japan)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Grifols, S.A. (Spain)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Fresenius SE & Co. KGaA (Germany)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Haemonetics Corporation (U.S.)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Teleflex Incorporated (U.S.)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Redax (U.S.)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Medtronic (Ireland)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client